Scor­pi­on Cap­i­tal goes af­ter Twist Bio­science as lat­est syn­bio tar­get, com­par­ing biotech to Ther­a­nos

The in­fa­mous short sell­er who went af­ter Gink­go Bioworks last year has a new tar­get in its sights.

Scor­pi­on Cap­i­tal re­leased a 236-page re­port Tues­day morn­ing fo­cused on Twist Bio­science, the syn­bio start­up led by Emi­ly Lep­roust that’s trad­ing down $TW­ST more than 27%. The re­lease wiped hun­dreds of mil­lions of dol­lars in mar­ket cap­i­tal and al­most 67% since Jan­u­ary 1.

We are short $TW­ST Twist Bio­science. Re­port now live at https://t.co/Os­xq0mB­nIL. Our third “syn­thet­ic bi­ol­o­gy” short re­port in a year af­ter $BLI and $DNA. The lat­est minia­tur­ized “lab-on-a-chip” scam, like Ther­a­nos, Berke­ley Lights, and oth­er fail­ures – and a tick­ing time bomb. pic.twit­ter.com/Eg4Hffn­tQQ

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER